|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.50 USD | -3.39% |
|
-4.19% | -6.58% |
| 02-06 | Centene sees 2026 profit above estimates signaling stabilizing costs | RE |
| 02-05 | Molina Healthcare forecasts 2026 profit below estimates as costs weigh; shares slide | RE |
| Capitalization | 72.28B 60.73B 55.51B 52.88B 98.11B 6,556B 102B 646B 256B 3,151B 271B 266B 11,279B | P/E ratio 2026 * |
13.7x | P/E ratio 2027 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise value | 93.8B 78.81B 72.03B 68.62B 127B 8,509B 132B 838B 332B 4,089B 352B 345B 14,637B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.47x |
| Free-Float |
99.81% | Yield 2026 * |
2.16% | Yield 2027 * | 2.3% |
Last Transcript: Elevance Health, Inc.
| 1 day | -3.39% | ||
| 1 week | -4.19% | ||
| Current month | -5.28% | ||
| 1 month | -12.16% | ||
| 3 months | +3.06% | ||
| 6 months | +11.40% | ||
| Current year | -6.58% |
| 1 week | 324.67 |  | 346.88 |
| 1 month | 315.46 | | 383 |
| Current year | 315.46 | | 383 |
| 1 year | 273.71 | | 458.75 |
| 3 years | 273.71 | | 567.26 |
| 5 years | 273.71 | | 567.26 |
| 10 years | 114.85 | | 567.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 65 | 2017-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 47 | 2023-10-31 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
CHM | Chairman | 70 | - |
Robert Dixon
BRD | Director/Board Member | 70 | 2011-06-30 |
Lewis Hay
BRD | Director/Board Member | 70 | 2013-06-30 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.18% | 3.22% | 26 M€ | |
| -.--% | 2.07% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.39% | -4.19% | -16.33% | -32.56% | 72.28B | |
| -0.34% | -3.46% | -47.69% | -43.24% | 250B | |
| +0.80% | +8.42% | +2.68% | +0.99% | 78.64B | |
| -2.29% | +1.22% | -30.93% | -61.48% | 22.79B | |
| -1.09% | -11.12% | -35.46% | -46.84% | 18.71B | |
| -3.18% | -29.61% | -55.09% | -57.68% | 6.56B | |
| -4.55% | -8.34% | +40.84% | +86.02% | 4.15B | |
| -1.37% | -10.57% | -1.23% | -30.90% | 1.87B | |
| Average | -1.91% | -7.42% | -17.90% | -23.21% | 56.84B | |
| Weighted average by Cap. | -0.77% | -2.19% | -31.76% | -33.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 195B 164B 150B 143B 265B 17,679B 275B 1,742B 689B 8,496B 731B 716B 30,413B | 201B 169B 154B 147B 272B 18,192B 283B 1,792B 709B 8,742B 752B 737B 31,295B |
| Net income | 5.24B 4.41B 4.03B 3.84B 7.12B 476B 7.4B 46.85B 18.54B 229B 19.66B 19.26B 818B | 5.64B 4.74B 4.33B 4.13B 7.66B 512B 7.96B 50.44B 19.96B 246B 21.17B 20.73B 881B |
| Net Debt | 21.52B 18.08B 16.53B 15.75B 29.22B 1,952B 30.37B 192B 76.12B 938B 80.72B 79.06B 3,359B | 21.55B 18.1B 16.55B 15.76B 29.25B 1,954B 30.41B 193B 76.21B 939B 80.81B 79.15B 3,362B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-09 | 327.50 $ | -3.39% | 1,966,549 |
| 26-02-06 | 338.98 $ | +2.03% | 2,055,053 |
| 26-02-05 | 332.25 $ | -2.45% | 1,831,813 |
| 26-02-04 | 340.60 $ | +0.58% | 1,634,701 |
| 26-02-03 | 338.65 $ | -0.93% | 1,568,173 |
Delayed Quote Nyse, February 09, 2026 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition